» Articles » PMID: 21593294

Benefits of Modest Weight Loss in Improving Cardiovascular Risk Factors in Overweight and Obese Individuals with Type 2 Diabetes

Overview
Journal Diabetes Care
Specialty Endocrinology
Date 2011 May 20
PMID 21593294
Citations 709
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Overweight and obese individuals are encouraged to lose 5-10% of their body weight to improve cardiovascular disease (CVD) risk, but data supporting this recommendation are limited, particularly for individuals with type 2 diabetes.

Research Design And Methods: We conducted an observational analysis of participants in the Look AHEAD (Action For Health in Diabetes) study (n=5,145, 40.5% male, 37% from ethnic/racial minorities) and examined the association between the magnitude of weight loss and changes in CVD risk factors at 1 year and the odds of meeting predefined criteria for clinically significant improvements in risk factors in individuals with type 2 diabetes.

Results: The magnitude of weight loss at 1 year was strongly (P<0.0001) associated with improvements in glycemia, blood pressure, triglycerides, and HDL cholesterol but not with LDL cholesterol (P=0.79). Compared with weight-stable participants, those who lost 5 to <10% ([means±SD] 7.25±2.1 kg) of their body weight had increased odds of achieving a 0.5% point reduction in HbA1c (odds ratio 3.52 [95% CI 2.81-4.40]), a 5-mmHg decrease in diastolic blood pressure (1.48 [1.20-1.82]), a 5-mmHg decrease in systolic blood pressure (1.56 [1.27-1.91]), a 5 mg/dL increase in HDL cholesterol (1.69 [1.37-2.07]), and a 40 mg/dL decrease in triglycerides (2.20 [1.71-2.83]). The odds of clinically significant improvements in most risk factors were even greater in those who lost 10-15% of their body weight.

Conclusions: Modest weight losses of 5 to <10% were associated with significant improvements in CVD risk factors at 1 year, but larger weight losses had greater benefits.

Citing Articles

Anti-obesity medication for weight loss in early nonresponders to behavioral treatment: a randomized controlled trial.

Tronieri J, Ghanbari E, Chevinsky J, LaFata E, Minnick A, Rajpal S Nat Med. 2025; .

PMID: 40055520 DOI: 10.1038/s41591-025-03556-3.


Advance in peptide-based drug development: delivery platforms, therapeutics and vaccines.

Xiao W, Jiang W, Chen Z, Huang Y, Mao J, Zheng W Signal Transduct Target Ther. 2025; 10(1):74.

PMID: 40038239 PMC: 11880366. DOI: 10.1038/s41392-024-02107-5.


Weight and cardiometabolic effects of a novel oral shape-shifting superabsorbent hydrogel capsule: Prespecified and exploratory analysis of the Epitomee capsule RESET study.

Bays H, Ard J, ONeil P, Wadden T, Kushner R, Jakicic J Obes Pillars. 2025; 13:100163.

PMID: 40028615 PMC: 11870181. DOI: 10.1016/j.obpill.2025.100163.


Exploring the Potential of Bambara Groundnut Flour as an Alternative for Diabetic and Obese Patients in the USA: A Comprehensive Review.

Odeniran O Cureus. 2025; 17(1):e78258.

PMID: 40026940 PMC: 11871983. DOI: 10.7759/cureus.78258.


Postoperative Weight Loss After Antiobesity Medications and Revision Risk After Joint Replacement.

Xie D, Englund M, Lane N, Zhang Y, Li X, Wei J JAMA Netw Open. 2025; 8(2):e2461200.

PMID: 39982723 PMC: 11846009. DOI: 10.1001/jamanetworkopen.2024.61200.


References
1.
Ryan D, Espeland M, Foster G, Haffner S, Hubbard V, Johnson K . Look AHEAD (Action for Health in Diabetes): design and methods for a clinical trial of weight loss for the prevention of cardiovascular disease in type 2 diabetes. Control Clin Trials. 2003; 24(5):610-28. DOI: 10.1016/s0197-2456(03)00064-3. View

2.
Wadden T, Anderson D, Foster G . Two-year changes in lipids and lipoproteins associated with the maintenance of a 5% to 10% reduction in initial weight: some findings and some questions. Obes Res. 1999; 7(2):170-8. DOI: 10.1002/j.1550-8528.1999.tb00699.x. View

3.
Kris-Etherton P, Krummel D, Russell M, Dreon D, Mackey S, Borchers J . The effect of diet on plasma lipids, lipoproteins, and coronary heart disease. J Am Diet Assoc. 1988; 88(11):1373-400. View

4.
Wadden T, West D, Delahanty L, Jakicic J, Rejeski J, Williamson D . The Look AHEAD study: a description of the lifestyle intervention and the evidence supporting it. Obesity (Silver Spring). 2006; 14(5):737-52. PMC: 2613279. DOI: 10.1038/oby.2006.84. View

5.
Blackburn G . Effect of degree of weight loss on health benefits. Obes Res. 1995; 3 Suppl 2:211s-216s. DOI: 10.1002/j.1550-8528.1995.tb00466.x. View